Global risk of cardiovascular disease - PubMed (original) (raw)
Review
Global risk of cardiovascular disease
N Poulter. Heart. 2003 May.
Abstract
UK death rates from coronary heart disease are among the highest in the world. This is because the UK has high levels of standard risk factors and a low level of intervention on those risk factors. The most important modifiable cardiovascular risk factors are dyslipidaemia (particularly high LDL cholesterol and low HDL cholesterol), smoking, hypertension, glucose intolerance, and central obesity. Intervention strategies that do not target those individuals at highest cardiovascular risk are likely to be less cost effective. Global risk estimation is increasingly recognised by management guidelines as a clinically and cost effective means of guiding treatment. However, an over reliance on short term absolute risk may result in under treatment of young people (particularly women) at high relative risk and over treatment of older people (particularly men) at low relative risk.
Figures
Figure 1
Does the Framingham risk function accurately predict CHD risk in a European population? Adapted from Haq et al,14 with permission.
Similar articles
- [The role of lipid metabolism in the prevention of coronary heart disease].
Mathes P, Thiery J. Mathes P, et al. Z Kardiol. 2005;94 Suppl 3:III/43-55. doi: 10.1007/s00392-005-1307-x. Z Kardiol. 2005. PMID: 16258792 German. - [Statins in primary prevention of coronary heart disease].
Paulweber B. Paulweber B. Wien Med Wochenschr. 1999;149(5-6):129-38. Wien Med Wochenschr. 1999. PMID: 10408004 Review. German. - Plasma triglyceride level and mortality from coronary heart disease.
Criqui MH, Heiss G, Cohn R, Cowan LD, Suchindran CM, Bangdiwala S, Kritchevsky S, Jacobs DR Jr, O'Grady HK, Davis CE. Criqui MH, et al. N Engl J Med. 1993 Apr 29;328(17):1220-5. doi: 10.1056/NEJM199304293281702. N Engl J Med. 1993. PMID: 8464432 - Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.
Evans M, Roberts A, Davies S, Rees A. Evans M, et al. Drugs. 2004;64(11):1181-96. doi: 10.2165/00003495-200464110-00003. Drugs. 2004. PMID: 15161326 Review. - Relationship between LDL-C and non-HDL-C levels and clinical outcome in the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study.
Athyros VG, Mikhailidis DP, Papageorgiou AA, Symeonidis AN, Daskalopoulou SS, Kakafika AI, Pehlivanidis AN, Bouloukos VI, Langer A; GREACE Study Collaborative Group. Athyros VG, et al. Curr Med Res Opin. 2004 Sep;20(9):1385-92. doi: 10.1185/030079904125004484. Curr Med Res Opin. 2004. PMID: 15383187 Clinical Trial.
Cited by
- Shuangyu Tiaozhi Granule Attenuates Hypercholesterolemia through the Reduction of Cholesterol Synthesis in Rat Fed a High Cholesterol Diet.
Shi J, Li R, Liu Y, Lu H, Yu L, Zhang F. Shi J, et al. Biomed Res Int. 2019 Feb 27;2019:4805926. doi: 10.1155/2019/4805926. eCollection 2019. Biomed Res Int. 2019. PMID: 30937311 Free PMC article. - Improving mortality prediction using biosocial surveys.
Goldman N, Glei DA, Lin YH, Weinstein M. Goldman N, et al. Am J Epidemiol. 2009 Mar 15;169(6):769-79. doi: 10.1093/aje/kwn389. Epub 2009 Jan 15. Am J Epidemiol. 2009. PMID: 19147742 Free PMC article. - Childhood adversity, adult neighborhood context, and cumulative biological risk for chronic diseases in adulthood.
Slopen N, Non A, Williams DR, Roberts AL, Albert MA. Slopen N, et al. Psychosom Med. 2014 Sep;76(7):481-9. doi: 10.1097/PSY.0000000000000081. Psychosom Med. 2014. PMID: 25077427 Free PMC article. - Association of Established Blood Pressure Loci With 10-Year Change in Blood Pressure and Their Ability to Predict Incident Hypertension.
Poveda A, Atabaki-Pasdar N, Ahmad S, Hallmans G, Renström F, Franks PW. Poveda A, et al. J Am Heart Assoc. 2020 Aug 18;9(16):e014513. doi: 10.1161/JAHA.119.014513. Epub 2020 Aug 4. J Am Heart Assoc. 2020. PMID: 32805198 Free PMC article.
References
- Lancet. 2002 Sep 21;360(9337):942-4 - PubMed
- Br Med J (Clin Res Ed). 1986 Aug 23;293(6545):474-9 - PubMed
- Br Heart J. 1988 Nov;60(5):397-403 - PubMed
- Circulation. 2002 Jan 22;105(3):310-5 - PubMed
- BMJ. 1995 Jul 15;311(6998):171-4 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources